147 Episodo

  1. Biosimilar Drugs for Retinal Diseases

    Publicado: 6/7/2023
  2. Faricimab vs Aflibercept in Diabetic Macular Edema

    Publicado: 29/6/2023
  3. Artificial Intelligence in the Management of Geographic Atrophy

    Publicado: 22/6/2023
  4. Molecular Diagnostics in the Diagnosis and Treatment of Uveal Melanoma

    Publicado: 15/6/2023
  5. Faricimab in the Treatment of Retinal Venous Occlusion

    Publicado: 8/6/2023
  6. The Use of High Dose Aflibercept in Diabetic Macular Edema

    Publicado: 1/6/2023
  7. Widefield OCT Angiography

    Publicado: 25/5/2023
  8. Aflibercept Therapy of Retinopathy of Prematurity

    Publicado: 18/5/2023
  9. Home OCT in the Management of Neovascular AMD: Latest Development

    Publicado: 11/5/2023
  10. Suprachoroidal Corticosteroids for the Treatment of Macular Edema

    Publicado: 4/5/2023
  11. The Use of the Port Delivery System for the Treatment of Diabetic Macular Edema

    Publicado: 27/4/2023
  12. Suprachoroidal Therapy of Neovascular AMD

    Publicado: 20/4/2023
  13. Microperimetry in the Assessment of Geographic Macular Atrophy

    Publicado: 13/4/2023
  14. Subretinal Gene Therapy for Neovascular AMD

    Publicado: 6/4/2023
  15. A Tyrosine Kinase Inhibitor Implant for the Treatment of Neovascular AMD

    Publicado: 30/3/2023
  16. 15 Year Results of Fixed Dose Anti-VEGF Treatment of Neovascular AMD

    Publicado: 23/3/2023
  17. Dexamethasone Implant for Treating Diabetic Macular Edema

    Publicado: 16/3/2023
  18. Retinal Vasculitis Update

    Publicado: 2/3/2023
  19. Central Serous Chorioretinopathy

    Publicado: 23/2/2023
  20. Faricimab Update

    Publicado: 16/2/2023

3 / 8

Retina Synthesis is a data-focused resource exploring therapies in development for retinal diseases.

Visit the podcast's native language site